Lilly to cut insulin price; Novo Nordisk offers options
Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to Chairman and CEO Dave Ricks. Meanwhile, Novo Nordisk, which operates a huge insulin manufacturing plant in Johnston County, says it offers a variety of means to help patients reduce costs.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed